Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. (ONCT) Stock Overview
Explore Oncternal Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.6M
P/E Ratio
-0.05
EPS (TTM)
$-11.69
ROE
-1.78%
ONCT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Oncternal Therapeutics, Inc. (ONCT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.40.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.05 and a market capitalization of 1.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.